Dental AI imaging has matured from a novelty into a core technology decision for growing DSOs. Two names dominate the conversation: Overjet and Pearl. Both offer FDA-cleared AI that analyzes dental radiographs in real time, but they differ meaningfully in regulatory depth, go-to-market strategy, analytics capabilities, and pricing philosophy. This comparison breaks down what DSO decision-makers need to know before choosing between them.
Overview
Overjet, founded in 2018 out of MIT and Harvard, has built its platform around dual-market positioning: clinical decision support for dental practices and automated claim review for insurance carriers. The company has secured multiple FDA clearances covering caries detection, bone level measurements for periodontal disease, and dental restorations analysis. Overjet has raised over $100 million in venture funding and counts major insurance carriers like Guardian and Delta Dental among its partners, alongside large DSO deployments.
Pearl, founded in 2019, has focused squarely on the clinical practice side with its flagship Second Opinion product. Pearl holds FDA clearance for its AI that detects a wide range of dental conditions on radiographs, including caries, periapical lesions, calculus, and more. The company has also developed Practice Intelligence, an analytics suite that mines imaging data across a dental organization. Pearl reports deployment across thousands of dental practices and has raised significant venture capital to fuel its growth.
Overjet Strengths
Overjet’s strongest differentiator is its dual-sided network effect. Because the same AI engine serves both dental providers and insurance payers, DSOs using Overjet can benefit from faster claim adjudication and fewer denials when their insurer partners also use the platform. This payer-provider alignment is unique in the dental AI space.
- Multiple FDA clearances — Overjet holds several individual FDA 510(k) clearances covering distinct clinical indications including caries, bone loss quantification, and dental restorations, giving it one of the broadest regulatory portfolios in dental AI.
- Insurance integration — Overjet’s payer-side platform processes millions of claims for major carriers, creating a feedback loop that strengthens its clinical AI and can reduce friction for DSOs at the billing stage.
- Quantitative bone loss measurements — Rather than simply flagging bone loss as present, Overjet measures it in millimeters and as a percentage, giving periodontists and hygienists precise, defensible data for treatment planning.
- Proven enterprise scale — Overjet has demonstrated the ability to deploy across large, multi-location organizations with centralized dashboards and reporting.
Pearl Strengths
Pearl has carved out a strong position with a product that prioritizes clinical breadth and practice-level analytics. Its Second Opinion platform is designed to be an always-on safety net during diagnosis, while Practice Intelligence turns imaging data into organizational insights.
- Broad pathology detection — Pearl’s Second Opinion is FDA-cleared to detect a wide array of conditions including caries, periapical lesions, calculus, margin discrepancies on existing restorations, and more, often cited as one of the widest detection scopes in a single product.
- Practice Intelligence analytics — This add-on product aggregates diagnostic data across locations, enabling DSO leaders to benchmark clinical consistency, identify underdiagnosis patterns, and track provider performance without chart-by-chart auditing.
- Imaging system agnostic — Pearl integrates with virtually every major imaging sensor and practice management system, which reduces friction during rollout across heterogeneous DSO environments where different offices may use different hardware.
- Patient communication tools — Pearl’s visual overlays help clinicians show patients exactly what the AI detected, which DSOs report improves case acceptance rates.
Head-to-Head Comparison
FDA and Regulatory Depth: Both companies hold FDA 510(k) clearances for dental AI diagnostics. Overjet distinguishes itself with multiple individual clearances across different clinical indications, while Pearl has consolidated a broad range of detections under its Second Opinion clearance. For DSOs, the practical difference is less about the number of clearances and more about which specific conditions matter most to your clinical protocols.
Clinical Accuracy: Both platforms report high sensitivity and specificity for caries and periodontal conditions in peer-reviewed studies and clinical validation datasets. Overjet has published extensively on bone loss measurement accuracy, while Pearl emphasizes its multi-condition detection breadth. Independent head-to-head clinical trials remain limited, so DSOs should request pilot data specific to their patient mix.
Pricing: Both companies typically price on a per-provider or per-location monthly subscription basis. Overjet may offer bundled pricing advantages for DSOs whose insurance partners are already on the platform. Pearl’s pricing is often described as straightforward per-seat SaaS. Neither company publishes list prices, so expect negotiated enterprise agreements for any multi-location deployment.
DSO Analytics: Pearl’s Practice Intelligence is a purpose-built analytics layer that gives DSO leadership visibility into diagnostic patterns, provider variability, and missed findings across all locations. Overjet provides enterprise dashboards and reporting, but its analytics have historically focused more on the payer side. DSOs that prioritize clinical oversight and standardization may find Pearl’s analytics more immediately actionable.
Integration Ecosystem: Overjet’s payer relationships create a unique ecosystem advantage, potentially smoothing claim workflows. Pearl’s wide sensor and PMS compatibility makes it a flexible choice for DSOs with mixed technology stacks. Both integrate with major practice management platforms, but DSOs should verify compatibility with their specific systems during evaluation.
Which One Should Your DSO Choose?
The right choice depends on your DSO’s strategic priorities. If your organization processes a high volume of insurance claims and works with carriers that already use Overjet on the payer side, the network effects and potential for smoother claim adjudication make Overjet compelling. Overjet is also the stronger pick for DSOs that need granular, quantitative periodontal measurements as a core clinical requirement.
If your primary goal is clinical standardization across diverse locations, provider performance benchmarking, and broad-spectrum pathology detection with strong patient communication tools, Pearl offers a more practice-centric solution. Its Practice Intelligence module is particularly attractive for DSO clinical directors who need organizational-level visibility without auditing individual charts.
For mid-sized DSOs evaluating both, consider running parallel pilots at a few locations with each platform. Measure impact on diagnostic yield, case acceptance, claim outcomes, and provider satisfaction before committing to an enterprise rollout. Both vendors typically support pilot programs.
Bottom Line
Overjet and Pearl are both proven, FDA-cleared dental AI platforms with real DSO deployments and meaningful clinical utility. Overjet’s payer-provider dual positioning and quantitative periodontal analysis set it apart for organizations focused on the insurance workflow and perio-heavy practices. Pearl’s breadth of detection, practice analytics, and patient engagement features make it the stronger choice for DSOs prioritizing clinical consistency and case acceptance. Neither is a wrong answer. The question is which strategic lens matters most to your organization today and where you see the biggest return on your AI investment over the next three to five years.